PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that its RenalGuard System(TM) will be utilized as part of a live case transmission from the Clinica Mediterranea, Naples, Italy, to the 30th Congresso Nazionale della Societa' Italiana di Cardiologia Invasiva (GISE) during the conference. The conference takes place October 20-23, 2009 in Bologna, Italy. Artech s.r.l., the exclusive distributor for RenalGuard in Italy, will also demonstrate RenalGuard as part of its exhibit at the conference.
Dr. Carlo Briguori, Chief of the Laboratory of Interventional Cardiology, Clinica Mediterranea, a noted expert on CIN, is currently conducting an investigator-sponsored multi-center randomized clinical trial on the efficacy of RenalGuard® at his hospital. He plans to make a presentation on the status of his study at GISE, and will include a video demonstrating the use of RenalGuard during his talk.
This live case transmission marks the second time RenalGuard has been utilized as part of a live case transmission during a cardiac procedure during a cardiology conference. In May 2009, RenalGuard was included as part of a live case transmission from Hospital Clinico San Carlos, Madrid, Spain, during the meeting of EuroPCR. The interventional cardiologists involved in that case demonstrated how RenalGuard is used to help prevent Contrast-Induced Nephropathy (CIN) in a patient with impaired renal function undergoing a Percutaneous Coronary Intervention (PCI).